The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Lieberman, J. A.
* Articles by Puig-Antich, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Lieberman, J. A.
* Articles by Puig-Antich, J.

Am J Psychiatry 1985; 142:747-751
Copyright © 1985 by American Psychiatric Association


REGULAR ARTICLES

Dexamethasone suppression tests in patients with obsessive-compulsive disorder

JA Lieberman, JM Kane, S Sarantakos, K Cole, A Howard, M Borenstein, H Novacenko and J Puig-Antich

Obsessive-compulsive disorder and major depressive disorder are associated by several lines of evidence. To explore the possible relationship between the two disorders, the authors administered 1-mg dexamethasone suppression tests to 18 patients with obsessive- compulsive disorder and 51 patients with major depressive disorder. None of the obsessive-compulsive patients were classified as nonsuppressors on the basis of a 4:00 p.m. serum cortisol level, whereas 37% of the depressed patients were nonsuppressors. The mean cortisol levels of the two groups differed significantly. Factors that may influence hypothalamic-pituitary-adrenal function, such as age, depressive symptoms, and severity of illness, are discussed in light of these results.


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
J.V. Lucey
BAP/SKB Young Psychopharmacologist Award Towards a neuroendocrinology of obsessive-compulsive disorder
J Psychopharmacol, January 1, 1994; 8(4): 250 - 257.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1985 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org